Concepedia

Neil P. Shah

NP

125

Publications

13.5K

Citations

47

H-Index

1985

Active since

Affiliations

University of California, San Francisco(Current)

The University of Texas MD Anderson Cancer Center

University of California, Los Angeles

Bristol-Myers Squibb (United States)

University of Michigan

Neil P. Shah is an author at University of California, San Francisco specializing in medicine, cell biology, and oncology.

Top concepts

MedicineOncologyHematologyCell BiologyCancer ResearchRadiation OncologyPharmacotherapyHealthPharmacologyImmunology

Publications per year

1985–2024

125

Publications

125

Overriding Imatinib Resistance with a Novel ABL Kinase Inhibitor

Neil P. Shah, Chris Tran, Francis Y. Lee et al. · Science · 2004 · 1.8K citations

Imatinib Resistance, Imatinib-resistant Bcr-abl Mutants, Chronic Myeloid Leukemia +14

A Phase 2 Trial of Ponatinib in Philadelphia Chromosome–Positive Leukemias

Jörge E. Cortes, D. W. Kim, Javier Pinilla‐Ibarz et al. · New England Journal of Medicine · 2013 · 1.1K citations · Full text

Dynamics of chronic myeloid leukaemia

Franziska Michor, Timothy P. Hughes, Yoh Iwasa et al. · Nature · 2005 · 848 citations

Hematological Malignancy, Tumor Biology, Chronic Myeloid Leukaemia +7

Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia

Catherine C. Smith, Qi Wang, Chen-Shan Chin et al. · Nature · 2012 · 734 citations

Hematological Malignancy, Medicine, Mixed-phenotype Acute Leukemia +10

Ponatinib efficacy and safety in Philadelphia chromosome–positive leukemia: final 5-year results of the phase 2 PACE trial

Jörge E. Cortes, Dong‐Wook Kim, Javier Pinilla‐Ibarz et al. · Blood · 2018 · 572 citations · Full text

Rows per page

1–5 of 125